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Summary A case-control study of the aetiology of testicular cancer was conducted using information
obtained by interview and from case-notes of 259 cases with testicular cancer and two sets of control patients
- 238 men with diagnoses other than testicular cancer attending the same radiotherapy centres as those
attended by the cases, and 251 hospital in-patients not attending radiotherapy departments. Logistic
regrcssion analyses were performed, after stratifying by age and region of residence, to estimate the relative
risks (RRs) associated with various aspects of prior medical history. The risk of testicular cancer was found
to be raised for men with a history of cryptorchidism (RR based on comparison with all controls=6.3;
P<0.001), inguinal hernia (RR= 1.6; P=0.14), mumps orchitis (RR= 12.7; P=0.006), atopy (RR= 1.8;
P=0.03), and meningitis (RR=3.0; P=0.21). Inguinal herniorrhaphy before the age of 15 years was
particularly a risk factor for seminoma, whereas the relative risks were similar for seminoma and teratoma
for the other factors. The results add to the growing evidence that congenital abnormalities involving the
process of testicular descent and closure of the processus vaginalis are risk factors for testicular cancer, and
that some types of testicular damage later in life may also be important. The findings of associations with
previous atopy and certain infections suggest a possible second aetiological mechanism - that immunological
abnormalities may be associated with an increased risk of testis cancer.
Testicular cancer is one of the commonest cancers in young
men and is increasing in incidence in adults in many
white populations, but its aetiology remains largely unknown.
There is growing evidence of an aetiological role for pre-
natal factors (Henderson et al., 1979; Loughlin et al., 1980;
Schottenfeld et al., 1980; Depue et al., 1983), and testis
cancer is associated with some congenital malformations
involving abnormalities of genito-urinary tract development.
Associations have been shown with cryptorchidism, which is
found in about 10% of eases (Morrison, 1976; Henderson et
al., 1979; Schottenfeld et al., 1980; Depue et al., 1983; Mills
et al., 1984; Pottern et al., 1985), inguinal hernia (Li &
Fraumeni, 1972; Morrison, 1976; Swerdlow et al., 1982;
Depue et al., 1983) and, for childhood testicular cancer,
congenital genito-urinary abnormalities other than crypt-
orchidism (Li and Fraumeni, 1972; Sakashita et al., 1980;
Swerdlow et al., 1982). Adult, but not childhood, testicular
cancer incidence has increased in white populations in recent
years which suggests that postnatal factors may also be
important in the aetiology of the adult disease. Mumps
orchitis appears to be an uncommon postnatal cause of the
tumour (Beard et al., 1977a; Lin and Kessler, 1979), but
there has been little investigation of postnatal disease
associations.
The present study examined associations between various
previous diseases and testicular cancer in data collected in a
case-control study conducted in the environs of Oxford and
the West Midlands of England in 1979-81. The study was
large enough to permit separate examination of risk of
seminoma and teratoma for some factors.
Materials and methods
The study was a stratum-matched case-control study com-
paring risk factors in cases of testicular cancer with those in
two sets of controls who presented with other diseases
incident during the same period as the cases. The potential
cases were men with primary cancer of the testis incident
between January 1977 and February 1981 at age 10 years
or greater whilst resident in the catchment areas of the
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radiotherapy centres at Oxford, Reading, Northampton,
Cheltenham, Birmingham and Coventry. The potential cases
were identified from clinical department records, clinical
staff, hospital diagnostic indexes, Hospital Activity Analysis
(computerised regional data on hospital discharges and
deaths), cancer registries, and death certificates, in order to
try to achieve complete ascertainment.
Four hundred and sixty-nine testis cancers were incident in
residents of the study area from January 1977 to February
1981; 460 (98%) were known to have been histologically
verified. For 83 of the patients, the responsible consultant
did not permit interview (30 were under the care of one
consultant who would not allow interview of any of his
patients), and a further 30 had died before the study began.
Two hundred and fifty-four of the patients were interviewed
(71% of the 356 for whom approach for interview was
possible), 1 patient refused interview, 1 interview could not
be completed, 7 patients were not approached because they
had moved far from the study area, and 93 were not
interviewed for other reasons, mainly of infrequent follow-up
attendance, or because they were not ascertained before
death or before the study ended.
Because interviews were often conducted blind on patients
whom clinical staff had suggested were eligible for the study,
several patients were interviewed who subsequently proved
to be outside the study criteria. A small number of these
patients, although incident before 1977 were interviewed
sufficiently early in the study that their interval from presen-
tation to interview was within that which could occur under
the study protocol (i.e. 50 months, from January 1977 to
February 1981). These patients - 2 cases, 5 radiotherapy
controls and 1 non-radiotherapy control - have been
included in the analyses presented here. A further 3 cases
have been included in the analyses who were incident during
the study period and treated at study centres, but were
resident in areas just outside the study area (the catchments
for the treatment centres did not have completely clear-cut
borders in reality). The analyses therefore included 259 cases
with testicular cancer. The histologies of these tumours, as
stated in the pathology reports in the case notes, were: 138
seminoma, unmixed with other histological types; 104
teratoma, unmixed with other histological types; and 17
others, of mixed cell type or other cell types. This distri-
bution reflects British classificatory practice for histology of
testis cancer (Collins & Pugh, 1964) and hence several
pathological types common in US studies were not so
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classified in the present material. The age and histology
distribution of the cases (Table I) was similar to that for the
469 testis cancers incident in the catchment population,
except that the cases showed a deficit of elderly patients and
of patients with tumours of unknown histology (none of the
5 individuals in the latter category were interviewed).
Table I Age at presentation of cases of testis cancer included in the
case-control study, and of all patients with testis cancer resident in
the study catchment area, January 1977-February 1981.
Cases (0) All testis
cancers in
Age Other Total, catchment
(years) Teratoma Seminoma histologies all cases area (%)
<25 28 (27) 6 (4) 3 (18) 37 (14) 68 (14)
25-34 48 (46) 48 (35) 5 (29) 101 (39) 169 (36)
35-44 20 (19) 52 (38) 2 (12) 74 (29) 121 (26)
45-54 4 (4) 23 (17) 1 (6) 28 (11) 57 (12)
55-64 1 (1) 5 (4) 2 (12) 8 (3) 26 (6)
>65 3 (3) 4(3) 4 (24) 11 (4) 28 (6)
Total, all
ages 104 (100) 138 (100) 17 (100) 259 (100) 469 (100)
One control group was patients treated at the same
radiotherapy centres as the cases, with any diagnosis except
cancers of the testis, other genital organs, lung, and
unknown primary site (the 'radiotherapy controls'). Two
hundred and thirty-eight such controls were included in the
analyses; all but 3 were patients with cancer, most commonly
Hodgkin's disease (83 patients), non-Hodgkin's lymphoma
(31), brain tumour (23) and bladder cancer (18). The other
control group was in-patients from hospitals in the same
towns as the radiotherapy centres, with non-malignant
diseases excluding chronic diseases likely to affect lifestyle
substantially (the 'non-radiotherapy controls'). Two hundred
and fifty-one non-radiotherapy controls were included, with
a wide range of general surgical, orthopaedic, dental and
ENT conditions, most commonly deflected nasal septum (19
patients), disorders of tooth eruption (18), haemorrhoids
(16), acute tonsillitis (15), varicose veins of lower extremities
(13), nasal polyps (13), and appendicitis (13). An attempt
was made to select controls such that, within each centre
their age distribution was similar to that of the cases.
Cases and controls were interviewed in a similar manner
using a structured interview schedule between April 1979 and
March 1981 in hospitals (except in a very few instances
where, for practical reasons, interviews were conducted at
the patient's home or workplace); additional data were
extracted from hospital case-notes. The interviewers were,
where possible, 'blind' to the diagnoses of the cases and
radiotherapy controls; such blindness was not possible for
the non-radiotherapy controls. The subjects were not
informed of the specific disease of interest in the study, and
the questionnaire was constructed to give no obvious indi-
cation of the disease under investigation (for instance,
enquiry about cryptorchidism was made in a question asking
also about several other named congenital malformations).
The non-radiotherapy controls were interviewed, on average,
sooner after hospital presentation (4.4 months) than were the
cases (12.6 months) or the radiotherapy controls (9.8
months). This occurred partly because the radiotherapy
patients, unlike the non-radiotherapy controls, were often
interviewed at out-patient follow-up, and partly because the
radiotherapy patients usually presented to a surgeon but
could only be interviewed when they were subsequently
transferred to radiotherapy care. In order to compensate for
this difference when calculating age at 'presentation', a
pseudo-date of presentation for use in determining age was
calculated for each non-radiotherapy control by subtracting
from the patient's date of interview the mean duration from
hospital presentation to interview for the cases treated at the
same town.
The study investigated a large number of possible risk
factors; this report concerns the disease, operation, and drug
treatment associations of testicular cancer. Patients were
asked about any serious or chronic illnesses, and any
hospital admissions and operations, as well as specific
questions about several named infections, complications of
these infections, venereal diseases in the subject and his
partner(s), several named congenital abnormalities, inguinal
hernia, and (where appropriate) treatment of cryptorchidism.
Questions were also asked about all drugs taken at least once
per week for three months or more, about any medication
with androgens, oestrogens and other hormones, and about
taking of LSD. Information about illnesses and operations
was also extracted from available case notes - usually in
practice for testis cancer patients and radiotherapy controls
the radiotherapy department notes rather than the entire
hospital notes. The case notes rarely mentioned conditions
not also mentioned in the interview; such mentions did not
appear to be biased and were too few to have affected the
results substantially. Case note information did sometimes
allow clearer classification of conditions referred to in lay
terms by the subject at interview. Case note and interview
information have therefore been combined in the analyses
presented.
Analysis was by conditional logistic regression using the
computer program PECAN (Storer et al., 1983), estimating
relative risks after stratifying for age (using 2-year age
groupings between 20 and 49 years and the additional
groups <20, 50-54, 55-59, and >60 years) and two regions
of residence (West Midlands region, and Oxford region
including Cheltenham). This grouping of radiotherapy centre
catchments was on the basis of similarity of demographic
characteristics. The study data were examined with respect to
risks of testicular cancer overall and of sub-divisions of
testicular cancer by histology; the latter analyses have in
general only been presented where they indicated risks for
specific histologies different from those for testicular cancer
overall. Risks were examined separately in comparison with
each of the two control groups; such risks are presented in
the tables. Where risks were found to be similar using each
set of controls, the overall risks, based upon the two control
groups combined, are the ones presented in the text.
Controls who from their admission diagnoses were known to
be biased for particular analyses were excluded from those
analyses: thus, for example, a non-radiotherapy control who
was interviewed during an admission for resuture of vas was
excluded from analyses of risk associated with past
vasectomy.
Results
Cryptorchidism
The main known risk factor from previous studies, crypt-
orchidism, gave a relative risk (RR) for testicular cancer
overall of 6.3 (95% confidence limits (CL)=2.9-13.9;
seminoma RR=6.8; teratoma RR =5.7) (Table II). Fifteen
of the 27 cases and 5 of the 9 controls with a history of
cryptorchidism had undergone operation for maldescent,
although in 2 cases and 2 controls the operation was known
to have been unsuccessful (in one cases leading to subsequent
orchidectomy). In a further 3 cases and 1 control spontaneous
descent was stated to have occurred.
Only 2 cases had undergone successful orchidopexy before
the age of 10 years. There were too few controls who had
undergone the operation to analyse risk of malignancy by
age at orchidopexy, but there was some indication that long
uncorrected maldescent may be associated particularly with
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Table II Relative risk of testicular cancer in relation to selected conditions.
Number (%) of Relative risk, Relative risk, Relative risk
Number (%) of non- cases compared cases compared (95% CL),
Number (%) of radiotherapy radiotherapy to to non- cases compared
ofcases with controls with controls with radiotherapy radiotherapy to both control
Condition riskfactor riskfactor riskfactor controls controls groups combined
Cryptorchidism 27 (10) 6 (3) 3 (1) 4.7c 1O.5c 6.3 (2.9-13.9)c
Inguinal hernia 23 (9) 18 (8) 12 (5) 1.5 1.9 1.6 (0.9-2.9)
hernia without cryptorchidism 16 (6) 16 (7) 11 (4) 1.2 1.7 1.3 (0.7-2.7)
herniorrhaphy before age 15 years 8 (3) 4 (2) 3 (1) 2.2 2.4 2.3 (0.8-6.7)
herniorrhaphy before age 15 years
but no cryptorchidism 4 (2) 4 (2) 3 (1) 1.5 1.2 1.3 (0.4-4.7)
Mumps orchitis 5 (2) 1 (0) 0 (0) 6.0 (oc) 12.7 (1.4 113.6)b
Atopy 30 (12) 16 (7) 17 (7)d 1.6 2.1a 1.8 (1.1-3.1)a
hay fever 18 (7) 5 (2) 8 (3)d 2.9a 2.7a 2.6 (1.2-5.6)a
eczema 8 (3) 4 (2) 1 (O)d 1.9 7.7a 3.1 (1.0-10.0)
asthma 14 (5) 7 (3) 9 (4)d 1.7 1.7 1.7 (0.8-3.6)
Meningitis 4 (2) 1 (0) 1 (0) 2.6 3.9 3.0 (0.5-17.5)
Tuberculosis 4 (2) 2 (1) 2 (1) 3.3 2.2 2.7 (0.6-12.4)
Pneumonia 16 (6) 8 (3) 14 (6) 2.1 0.9 1.4 (0.7-2.8)
Total 259 (100) 238 (100) 251 (100)
ap<0.05; bp<o.o1; Cp<0.001; dfrom 234 controls (17 eliminated because diagnosis related to risk factor).
or therapeutic descent of the cryptorchid testis (all aged over
20 years at presentation) were seminomas, as was the only
case with orchidopexy after age 20 years.
Among the 18 cases with unilateral testis cancer and
unilateral cryptorchidism of known side, in 11 the cancer
was ipselateral to the maldescent and in 7 it was contra-
lateral. The mean age at incidence of testis cancer was
similar in cryptorchid men to that in non-cryptorchid men.
Inguinal hernia
Inguinal hernia was associated with a relative risk for
testicular cancer of 1.6 (NS) (Table II). Age at incidence of
the cancer was not affected by hernia history. All but 2
(both seminomas) of the 23 cases and all but I of the 30
controls who had had herniae had undergone herniorrhaphy.
Risk of testis cancer was raised for herniorrhaphy before age
15 years (RR=2.3; NS) but not later (RR=1.1); childhood
herniorrhaphy was particularly associated with seminoma
(RR=3.8; P<0.05), but this was not the case for later
herniorrhaphy. The age at first presentation of the hernia
was rarely known.
Of the 18 cases with unilateral testicular cancer and ever-
hernia of known side, the tumour occurred on the side of the
hernia in 7, and on the opposite side in 11. Testicular
cancers in men with herniae were predominantly left-sided
(16 left-sided tumours, 6 right-sided and I of unknown side);
this was due to a significant preponderance of left-sided
seminomas (13 left-sided, 3 right-sided; P<0.05). No such
preponderance was present in cases without herniae; 119
testis cancers were left-sided, 115 right-sided, and 2 bilateral.
Restricing the hernia analyses to men who never crypt-
orchid reduced the risks of testicular cancer for men with
hernia (RR= 1.3; NS) and with herniorrhaphy before age 15
years (RR=1.3; NS) but left a preponderance of left-side
tumours (13 left-sided, 3 right-sided (P<0.05)).
Mumps orchitis
Five cases (2 with seminoma, 3 with other histologies) and I
control had histories of mumps orchitis (RR= 12.7;
P<0.01). Mumps orchitis had occurred at age 15 years in
one case, and over 20 years in the remainder. The side of
orchitis was generally unknown, and only one case was
known to have had consequent testicular atrophy.
A history of mumps was associated with a significantly
raised risk when cases were compared to radiotherapy
controls (RR= 1.59; 95% CL 1.04-2.45) but not when
compared to non-radiotherapy controls (RR= 1.07; 95% CL
0.69-1.67) and not overall. Histories of other specific
infections - chickenpox, glandular fever, measles, rubella and
whooping cough - showed no significant association with
testicular cancer, although for measles the risk was of
borderline significance when comparison was with the radio-
therapy controls (RR= 1.79; 95% CL 0.98-3.26) but not
raised when comparison was with the non-radiotherapy con-
trols (RR= 1.07; 95% CL 0.57-2.00). Mumps had occurred
at age 15 years or over more often in cases (14 (7%)) than
in radiotherapy controls (5 (3%)) or non-radiotherapy
controls (8 (4%)); the excess partly reflected cases with
adult mumps orchitis, noted above.
Other genital conditions
Several other genital conditions showed non-significant
excesses in cases. Hydrocoele was recorded for 6 cases (5
ipselateral to the tumour, 1 bilateral hydrocoeles) and 3
controls. Two of the cases and 2 of the controls had
undergone operation for hydrocoele: the unoperated
coeles in cases had been diagnosed at the same time as the
cancer (1) or 1 or 2 years previously (2) or at an unknown
date (1). Testicular atrophy without a history of mumps
orchitis was recorded in 9 non-cryptorchid cases (3 with
atrophy ipselateral, 6 contralateral to the tumour) and no
controls, and epidydymitis or orchitis not known to be due
to mumps in 4 further cases (all seminomas; all ipselateral to
the tumour) but no controls. Hypospadias had been present
in 1 case and 2 controls, and varicocoele in 2 cases (both
with teratoma) and 3 controls. Testicular injury was not
specifically enquired about, but was volunteered at interview
by 6 cases and 1 control; none of these subjects had been
admitted to hospital for the injury.
Atopy
Atopy - taken as a history of asthma, hay fever or eczema -
was associated with a significantly raised risk of testicular
cancer (Table II: RR= 1.8; P<0.05). Risk was raised for
each of asthma, hay fever and eczema separately (Table II),
and was similarly raised for seminoma and teratoma. All but100 A.J. SWERDLOW et al.
one of the asthmatic cases and all but 3 of the asthmatic
controls were known to have had onset of asthma before age
15 years. Risk of testicular cancer was also raised for users
for at least 3 months of some categories of drugs which can
be used to treat atopy - steriods (RR= 1.9; NS), anti-
histamines (RR= 1.2; NS), and adrenoceptor stimulants
(RR=2.0; NS); three cases but no controls stated that they
had received a course of desensitising injections, and 2 cases
and 4 controls had used disodium cromoglycate. There was
no indication of raised risk for men using any of the above
drugs for non-atopic indications.
For a few subjects, there was a record of long term
treatment with a drug which can be used to treat atopic
conditions, but no record of an atopic condition or other
condition appropriate to the treatment. It seems likely that
some of these subjects had had atopic conditions which they
did not think merited mention when they were asked about
diseases (there were no interview questions specifically about
atopic conditions). The study records of such patients were
therefore examined by a medical colleague unaware of the
case-control status of the subjects; this identified 3 further
cases and I further control who were probably atopic and an
additional 2 cases and 1 control who probably had
bronchitis with an asthmatic component (none of whom
have been included in the above relative risk calculations).
Other diseases
There was an excess of cases with a history of meningitis
(RR=3.0; NS). The causative organism of meningitis was
always unknown; the age at infection varied considerably.
Non-significant excesses were also noted for histories of
tuberculosis (RR=2.7) and pneumonia (RR= 1.4), particu-
larly pneumonia before age 5 years (RR= 1.7; NS), but not
of bronchitis or other lung diseases. A history of epilepsy
was recorded for 3 cases and I control; all of the cases had
taken phenobarbitone, one had taken phenytoin, and one
had taken sodium valproate. The 469 potential cases for the
study included 2 patients with Down's syndrome and 8
others who were known to be mentally retarded.
Excepting the malformations discussed above, congenital
abnormalities of the urinary tract were known in I case (a
congenitally abnormal pelvic kidney found only during investi-
gation of the testicular cancer) and 2 controls, and other
congenital abnormalities (often minor or ill-specified, but
including 2 cases with serious congenital eye abnormalities)
in 10 cases and 10 controls. There was no raised risk for
other diseases or abnormal symptons of the urinary tract, or
for venereal diseases in the subjects or their partners. One
case had had a previous malignancy (a bladder cancer), and
a further 4 cases had had papillomata excised.
Opel ation1s
Risk in relation to some common operations is shown in
Table III. The tumour was not strongly associated with any
of these operations or the age at which they were performed.
Risks in relation to orchidopexy, herniorraphy and hydro-
coele operations have been discussed above; no other
operation was associated with risk of the tumour.
Drugs
There was no clear increased risk of testicular cancer associ-
ated with chronic use of any drug not discussed above, nor
with ever-use of androgens (1 case, 3 controls), oestrogens
(possibly 1 case, I control) or LSD (8 cases, 2 radiotherapy
controls, 8 non-radiotherapy controls).
Discussion
Cryptorchidism was found to be a major risk factor for
testicular cancer in this study, with a relative risk (6.3) which
is consistent with most previous epidemiologic findings. The
present results suggest that any greater risk of seminoma
than of teratoma in cryptorchidism may be due to a
particularly raised risk of seminoma associated with pro-
longed uncorrected maldescent. It is consistent with this that
in past studies which showed greater risk of seminoma than
of teratoma in cryptorchid patients (Collins & Pugh, 1964;
Miller & Seljelid, 1971; Morrison, 1976) the majority of the
cryptorchid subjects had had no successful treatment. Also,
data from a large clinical series (Batata et al., 1982) were in
the direction of particular risk of seminoma in uncorrected
cryptorchidism.
Testicular cancer in unilaterally cryptorchid males
occurred more often in the maldescended than in the
normally descended testis. Adding together the present and
previous published laterality data for men with unilateral
testicular cancer and unilateral cryptorchidism (Thurz6 &
Pinter 1961; Field, 1962; Collins & Pugh, 1964; Johnson et
al., 1968; Gehring et al., 1974; Morrison, 1976; Henderson et
al., 1979; Schottenfeld et al., 1980; Herman et al., 1981;
Batata et al., 1982; Coldman et al., 1982; Pottern et al.,
1985) gives a total of 318 tumours ipselateral and 65
tumours contralateral to maldescent - i.e. a risk 4.9 times
higher in the undescended than in the descended testis. This
implies that in comparison to the risk of malignancy in
descended testes generally, the risk in a descended testis
opposite maldescent is about 1H to 3 times raised (depending
upon the estimate used for overall risk of testis cancer in a
cryptorchid man). Totalling the present histology-specific
data and previous results published in sufficient detail
(Thurz6 & Pint&r, 1961; Field, 1962; Collins & Pugh, 1964;
Johnson et al., 1968; Gehring et al., 1974; Herman ct al.,
1981; Coldman et a!., 1982), suggests that the risk of
malignancy in a cryptorchid testis compared to that in a
contralateral descended testis is similar for seminoma (n =80,
ratio of risks =4.3) and for non-seminoma histologies
(n = 136, ratio=3.9).
Table III Relative risk of testicular cancer in relation to selected operations.
Relative risk Relative risk
Number (%) of (95% CL), (95% CL), Relative risk
Nunmber (%) of noni- cases conmpared cases compared (950% CL),
Numi1ber (%) of radiotherapy raliotherapy to to non- cases conmpared
cases wvith controls with controls wvith radiotherapy, radiotherapy to both control
Opercation risk factor risk ftctor risk factor? controls controls groups combined
Tonsils and adenoids operations 73 (28) 60 (25) 63 (27) 1.10 (0.72-1.67) 1.10 (0.72-1.68) 1.07 (0.75-1.52)
Circumcision and preputiotomy 47 (18) 54 (23) 54 (22) 0.69 (0.43-1.10) 0.67 (0.41-1.08) 0.69 (0.46-1.03)
Ligation of vas or vasectomy 22 (8) 16 (7) 20 (8) 1.28 (0.62-2.63) 0.99 (0.50-1.98) 1.13 (0.63-2.04)
Operations on appendix 31 (12) 29 (12) 34 (14) 0.92 (0.52-1.63) 0.78 (0.45-1.36) 0.88 (0.55-1.42)
Total 259 (100) 238 (100) 251 (100)
cxcluding for each operation, controls whose current admission was for the same or a related operation (i.e. 17 tonsils and adenoids, 2
circumcision, 1 resuture of vas, 12 operations on appendix).TESTICULAR CANCER AND ANTECEDENT DISEASES 101
Full consideration of risk of testis cancer in crypt-
orchidism needs also to take account of the position of
maldescent and the nature and age of any treatment of the
condition; our study had insufficient numbers for any
confident conclusion on risks related to these issues. The
above risk estimates using varied sources of data are
necessarily crude and open to potential bias; furthermore,
case-control study and clinical series data on risk of
malignancy in cryptorchidism are problematic because of the
difficulty of determining reliably the past position of testes
which are not maldescended at the time of adult presen-
tation. Subjects may not know of cryptorchidism if spon-
taneous descent or successful treatment occurred at a young
age, or they may believe that they have been cryptorchid
when in fact they have had retracted testes or misdiagnosed
normally descended testes. A cohort study of malignancy in
cryptorchidism could provide more reliable data.
The relative risk of adult testis cancer found for men who
had ever had an inguinal hernia (1.6) was compatible with
that from previous studies (Henderson et al., 1979;
Schottenfeld et al., 1980; Mills et al., 1984; Pottern et al.,
1985). There is evidence that inguinal hernia is associated
with childhood testis cancer also (Li & Fraumeni, 1972;
Swerdlow et al., 1982). The present study, and a study confined
to seminomas (Coldman et al., 1982), suggested a higher risk
of adult testis cancer for men with a history of childhood
hernia than for those whose herniae manifested in adulthood.
This accords with the slightly higher risk of testis cancer
found in studies restricted to childhood herniae (Morrison,
1976; Depue et al., 1983) than in studies including herniae
at any age (Henderson et al., 1979; Schottenfeld et al., 1980;
Mills et al., 1984). Pottern et al. (1985), however, found
greatest risk for men with greatest age at herniorrhaphy,
although this was in a study where most of the herniorrha-
phies were in childhood.
The present work suggested that childhood hernia may
particularly be a risk factor for seminoma, as did the results
of Coldman et al. (1982) but not Morrison (1976).
As in some (Morrison, 1976; Henderson et al., 1979) but
not all (Gehring et al., 1974; Pottern et al., 1985) previous
studies, the side of testicular cancer was not related to the
side of inguinal hernia/herniorrhaphy in the present material.
Inguinal hernia is associated with undescended testis
(Scorer & Farrington, 1971; Marshall, 1982) and on this
basis alone some association between hernia and testis
cancer would be expected. The extent to which this explains
the raised risk of testis cancer associated with hernia is
unclear: in analyses of risk associated with hernia excluding
subjects with known cryptorchidism, Pottern et al. (1985) and
the present study found relative risks of 1.3, but relative
risks of about 3 were found in a study restricted to
seminomas (Coldman et al., 1982) and a study restricted to
herniae repaired in childhood (Morrison, 1976).
Mumps orchitis appears to be a risk factor for testis
cancer, but not a major one. Kaufman & Bruce (1963)
identified reports of 28 cases of testicular cancer following
mumps orchitis. Beard et al. (1977a) found 2 testicular
cancers in follow-up of 132 men with a history of mumps
orchitis, while in case-control studies Lin and Kessler (1979)
and the present study found significant risks of testis cancer
for men with mumps orchitis, and Mills et al. (1984) found a
significant risk for men with a history of orchitis (cause(s)
not specified in the publication). The balance of evidence
does not strongly suggest, however, that mumps without
clinical orchitis raises risk of the tumour: Morrison (1976)
and Henderson et al. (1979) found no increase in risk for
men with a history of mumps, there was not a clear increase
in the present study, whilst Loughlin et al. (1980) found a
borderline significant raised risk for such men. Mumps
orchitis can cause permanent damage to the germinal
epithelium and to Leydig-cell function (Adamopoulos et al.,
1978), and is more likely to cause tubular damage when it
occurs in adults rather than before puberty (Schottenfeld &
Warshauer, 1982). It is notable that all of the cases with a
history of mumps orchitis in the present study had had the
infection after childhood.
Testicular atrophy also appears to be associated with
testicular cancer. Microscopic and clinical atrophy occur
frequently in cryptorchidism (Scorer & Farrington, 1971).
Cancer in situ of the testis occurs in testes which are on
average smaller than normal, and, in unilateral cancer in situ,
smaller than the contralateral testis (Skakkebaek et al.,
1982). In the present study all 9 subjects with atrophy but
not cryptorchidism or mumps orchitis were cases, although
there was clearly potentital for reporting bias. In previous
series without control data, up to 40% of testis cancers have
occurred in atrophic testes (Hausfeld & Schrandt, 1965;
Beard et al., 1977b; Ehrengut & Schwartau, 1977) and 6% in
testes opposite atrophy (Ehrengut & Schwartau, 1977).
The present study is the third to show a raised risk of
testis cancer for men with hydrocoele (Schottenfeld et al.,
1980; Mills et al., 1984). In neither of the previous reports
was it clear how frequently the diagnosis of hydrocoele had
preceded the testicular cancer, and in the present study there
were very few cases with hydrocoele clearly preceding the
tumour; the association may be due to bias.
Congenital genito-urinary defects other than those above
appear to be associated with testicular cancer in children (Li
& Fraumeni, 1972; Sakashita et al., 1980; Swerdlow et al.,
1982), but there was no evidence for such an association in
adults in the present study, and only one previous study has
given evidence which might suggest raised risk in adults
(Henderson et al., 1979).
An unexpected result was the significant association of
testicular cancer with a history of atopy. The analysis of
atopy was restricted to asthma, hay fever and eczema
because it was not possible from the available histories to
infer the atopic status of individuals who had reported other
conditions such as drug 'allergies' and unspecified urticaria
which might have an atopic basis in some instances. There
were comparatively few individuals with these other con-
ditions, however, and their inclusion would not substantially
have altered the results. Asthma can occur without an atopic
basis in association with chronic bronchitis, generally at
older ages, but in the present findings onset of asthma had
generally been in childhood and none of the asthmatics gave
a history of bronchitis or other chronic obstructive airways
disease. The information on atopic conditions was taken
from the interview questions and case note data about
serious and chronic illnesses in general. Atopy may well have
been under-recorded in both cases and controls, since the
study did not specifically enquire about any atopic con-
ditions by name (there was no prior hypothesis of an
association) and some subjects might well have regarded
atopic conditions as too trivial to volunteer at interview;
since the interview asked about all chronic drug treatments,
however, few if any patients with severe atopy should have
been missed. Biased under-reporting or under-recording of
atopic conditions is improbable since the hypothesis of an
association appears not to have been published previously
and is unlikely to have been suspected by the subjects or
interviewers; the cases did not have a substantial tendency to
disclose more diseases in general than did the controls;
similar raised risks for atopy were found for each set of
controls; and raised risks were found for each atopic
condition analysed separately. No potential condounding
variables for the association were apparent; no one type of
drug treatment of atopy was associated with a particularly
high risk.
Previous data on atopy and testis cancer are limited. A
cohort study of male asthmatics (Robinette & Fraumeni,
1978) found three testis cancer deaths compared to two
expected. In case-control studies, each with many fewer
cases than the present study, but each probably with con-
fidence limits compatible with the present findings,
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cancer for asthma or for hay fever, whilst Vena et al. (1985)
found non-significant relative risks of about 1.6 for testis
cancer in relation to histories of each of asthma, hay fever,
and hives - the highest risks they found for any cancer site
in males.
The risks of testicular cancer in men with meningitis does
not appear to have been investigated previously. Maternal
tuberculosis has previously been found a significant risk
factor for childhood testicular cancer (Swerdlow et al., 1982).
A history of pneumonia, which was a slight risk factor in the
present study, was significantly associated with risk of testis
cancer in a US cohort study (Whittemore et al., 1985). Like
the association with atopy, there is no reason to believe that
bias or confounding explained the associations with menin-
gitis, tuberculosis and pneumonia. The available evidence from
the literature, discussed above, gives some support to the notion
that the associations found with atopy, tuberculosis and
pneumoniamay notmerely bechance findings, although clearly
further investigation in other data sets is required. A
possible aetiological pathway can be suggested which would
link testis cancer to atopy, meningitis, tuberculosis and
pneumonia. Patients with atopy probably have deficiencies in
T-cell immunity (Buckley & Becker, 1978; Strannegard &
Strannegard, 1978). T-cells are also important in defence
against tuberculosis (Chaparas, 1982) and T-cell deficiency
may be associated with an increased susceptibility to
tuberculosis - in several conditions which include suppressed
cell mediated immunity there is an excess of tuberculosis
(Chaparas, 1982). There is also evidence that cell mediated
immunity, including T-cells, is of importance in immunity to
viruses causing respiratory infections (Ganguly & Waldman,
1982) and meningitis (Welliver et al., 1982). The T-cell is
though to play a central role in the immune response to
neoplasia (Rosenbaum & Dwyer, 1977), and epidemiological
evidence suggests (Kinlen, 1982) that immunological factors
are important in the development of some but not most
cancers in man. Testis cancer has in common with several of
these tumours that it does not increase steeply in incidence
with age. Cases of testis cancer have been reported in men
immunosuppressed after renal transplantation (Nellans &
Ravera, 1975; Cabrera et al., 1976) and in homosexual men
with cellular immune deficiency (Logothetis et al., 1985), but
excesses of testis cancer in follow-up of such men have not
at present been reported.
The evidence that atopy and certain infections are
associated with testicular cancer incidence needs replication.
Also, it may be worthwhile to investigate in aetiological
studies the immunological status of patients with early
testicular cancer.
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